3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
14
Thoracic
2
Genitourinary
2
Gastrointestinal
2
Dermatologic
2
Sarcoma
1
Other
1
Lymphoid
1
Head & Neck
1
CNS
1
Breast
1
Conditions
Sarcoma
19
Neoplasms
7
Osteosarcoma
5
Gastrointestinal Stromal Tumors
4
Neuroblastoma
3
Melanoma
3
Uterine Cervical Neoplasms
2
Testicular Neoplasms
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Lung Neoplasms
2
Glioma
2
Esophageal Neoplasms
2
Desmoid Tumors
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Brain Neoplasms
2
Wilms Tumor
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Somatostatinoma
1
Skin Neoplasms
1
Sarcoma, Myeloid
1
Sarcoma, Ewing
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neoplastic Cells, Circulating
1
Interventions
Paclitaxel
7
Specimen Handling
6
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
Biopsy
4
pembrolizumab
3
Taxes
3
Nivolumab
3
Carboplatin
3
trastuzumab deruxtecan
2
olaparib
2
ceralasertib
2
aflibercept
2
X-Rays
2
Psychiatric Rehabilitation
2
Irinotecan
2
Ipilimumab
2
Immunoglobulin G
2
Ifosfamide
2
Gene Expression Profiling
2
Fulvestrant
2
Filgrastim
2
Fentanyl
2
Doxorubicin
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
toripalimab
1
tinostamustine
1
spartalizumab
1
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Blood Specimen Collection
×
Sarcoma
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled